Related Experiment Video
Updated: Dec 7, 2025
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
[Use of medicinal plants in patients with symptoms of generalized anxiety]
Ofelia Romero-Cerecero1, Ana Laura Islas-Garduño2, Jaime Tortoriello-García2
1Instituto Mexicano del Seguro Social, Centro de Investigación Biomédica del Sur. Xochitepec, Morelos, México orcerecero@yahoo.com.mx.
Background:
Anxiety is one of the most common mental disorders. It has an impact on the decrease of productivity, the affectation of quality of life, and the increase in health care costs. The study of plant species with medicinal properties to treat anxiety has made significant progress, since they have been evaluated through in vitro, in vivo and clinical studies.
Objective:
To identify the use of medicinal plants among patients with symptoms of generalized anxiety disorder (GAD).
Material And Methods:
A diagnostic questionnaire, including the Hamilton Anxiety Rating Scale, and another related with the use of medicinal plants, was applied. It was designed specifically for this study, and it was used in subjects and/or their companions, who visited an Instituto Mexicano del Seguro Social hospital.
Results:
The study had 985 subjects, 802 women, with a median age of 37.1 ± 15.17; anxiety symptoms were identified in 95.9% (940); according to the number of signs and symptoms, 53.1% (523) of subjects may have suffered a moderate or severe degree of anxiety. 23.09% (187) used medicinal plants to treat their symptoms. 39 plant species were identified as used by patients with GAD symptoms. Of these, 76.3% (29) had a history of ethnomedical use on mental disorders.
Conclusions:
A high percentage of the population in Mexico presents symptoms of GAD. A significant number of patients use medicinal plants to treat the symptoms of anxiety, even when they do not know that their symptomatology is part of a mental disorder.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Related Concept Videos
01:26Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
01:30Generalized Anxiety Disorder
01:28Drug Therapy
Antianxiety Medications
01:18Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...